Accumulating evidence suggests that LMO1 and LMO2 act as oncogenic proteins in T-cell acute lymphoblastic leukemia, whereas LMO4 has recently been implicated in the genesis of breast cancer[61]. This evidence concerns the gene LMO2 and T-cell acute lymphoblastic leukemia.